Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of BrightSpring Health Services Inc (NASDAQ: BTSG) closed at $18.47 in the last session, down -0.91% from day before closing price of $18.64. In other words, the price has decreased by -$0.91 from its previous closing price. On the day, 0.76 million shares were traded. BTSG stock price reached its highest trading level at $18.87 during the session, while it also had its lowest trading level at $18.27.
Ratios:
We take a closer look at BTSG’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 1.33. In the meantime, Its Debt-to-Equity ratio is 1.76 whereas as Long-Term Debt/Eq ratio is at 1.68.
On June 21, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $15.BTIG Research initiated its Buy rating on June 21, 2024, with a $15 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 18 ’25 when Walgreens Boots Alliance, Inc. sold 12,000,000 shares for $21.16 per share. The transaction valued at 253,920,000 led to the insider holds 11,239,996 shares of the business.
Walgreen Co. bought 12,000,000 shares of BTSG for $265,800,000 on Feb 18 ’25. On Sep 11 ’24, another insider, Walgreens Boots Alliance, Inc., who serves as the 10% Owner of the company, sold 11,619,998 shares for $11.13 each. As a result, the insider received 129,330,578 and left with 23,239,996 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BTSG now has a Market Capitalization of 3261506304 and an Enterprise Value of 6068576256. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.29 while its Price-to-Book (P/B) ratio in mrq is 1.95. Its current Enterprise Value per Revenue stands at 0.539 whereas that against EBITDA is 11.165.
Stock Price History:
The Beta on a monthly basis for BTSG is 2.20, which has changed by 0.8346456 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, BTSG has reached a high of $24.82, while it has fallen to a 52-week low of $9.53. The 50-Day Moving Average of the stock is -7.87%, while the 200-Day Moving Average is calculated to be 15.67%.
Shares Statistics:
According to the various share statistics, BTSG traded on average about 1.53M shares per day over the past 3-months and 1435640 shares per day over the past 10 days. A total of 174.25M shares are outstanding, with a floating share count of 67.67M. Insiders hold about 61.33% of the company’s shares, while institutions hold 46.19% stake in the company. Shares short for BTSG as of 1741910400 were 8525420 with a Short Ratio of 5.56, compared to 1739491200 on 10022589. Therefore, it implies a Short% of Shares Outstanding of 8525420 and a Short% of Float of 15.340000000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
A detailed examination of BrightSpring Health Services Inc (BTSG) is currently in progress, with 10.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $0.12, with high estimates of $0.17 and low estimates of $0.07.
Analysts are recommending an EPS of between $0.69 and $0.43 for the fiscal current year, implying an average EPS of $0.56. EPS for the following year is $0.8, with 11.0 analysts recommending between $0.99 and $0.65.
Revenue Estimates
According to 11 analysts, the current quarter’s revenue is expected to be $2.74B. It ranges from a high estimate of $3.05B to a low estimate of $2.67B. As of the current estimate, BrightSpring Health Services Inc’s year-ago sales were $2.58BFor the next quarter, 11 analysts are estimating revenue of $2.9B. There is a high estimate of $3.22B for the next quarter, whereas the lowest estimate is $2.8B.
A total of 13 analysts have provided revenue estimates for BTSG’s current fiscal year. The highest revenue estimate was $13.06B, while the lowest revenue estimate was $11.77B, resulting in an average revenue estimate of $11.97B. In the same quarter a year ago, actual revenue was $11.27BBased on 13 analysts’ estimates, the company’s revenue will be $13.32B in the next fiscal year. The high estimate is $14.16B and the low estimate is $12.72B.
